NASDAQ:BABY

Natus Medical (BABY) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$26.75
$31.92
52-Week Range
N/A
Volume
22 shs
Average Volume
165,325 shs
Market Capitalization
$1.12 billion
P/E Ratio
23.21
Dividend Yield
N/A
Price Target
N/A
BABY stock logo

About Natus Medical Stock (NASDAQ:BABY)

Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.

BABY Stock News Headlines

This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Oh, Baby!
When is it safe to fly with a newborn baby?
See More Headlines
Receive BABY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/24/2018
Today
4/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:BABY
CUSIP
63905010
Fax
N/A
Employees
1,729
Year Founded
N/A

Profitability

Net Income
$-22,930,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$530.89 million
Book Value
$11.80 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.12 billion
Optionable
Optionable
Beta
0.57
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Jonathan A. Kennedy CPA (Age 48)
    Pres, CEO & Director
  • Mr. Benjamin Drew Davies (Age 53)
    Exec. VP & CFO
  • Mr. Austin F. Noll III (Age 52)
    Exec. VP & Chief Commercial Officer
  • Mr. Seán Langan
    VP Global Operations
  • Mr. Ivan Pandiyan
    VP of Global R&D

BABY Stock Analysis - Frequently Asked Questions

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) announced its earnings results on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.42 by $0.02. The medical equipment provider had revenue of $130.60 million for the quarter, compared to analyst estimates of $132.92 million. Natus Medical had a negative net margin of 7.38% and a positive trailing twelve-month return on equity of 10.79%. The company's quarterly revenue was up 6.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.40 earnings per share.

What other stocks do shareholders of Natus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include Starbucks (SBUX), Gilead Sciences (GILD), Activision Blizzard (ATVI), Walt Disney (DIS), Skyworks Solutions (SWKS), Intel (INTC), AbbVie (ABBV), Alphabet (GOOG) and NVIDIA (NVDA).

When did Natus Medical IPO?

Natus Medical (BABY) raised $9 million in an IPO on Wednesday, March 8th 2023. The company issued 1,766,618 shares at a price of $5.00 per share.

This page (NASDAQ:BABY) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners